Joint EMA/EORTC Workshop
29 February 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?”
This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam
Next events
ESOI Touchdown 2026
29 October @ 08:00 - 31 October @ 14:00
Heidelberg, DE
The EORTC Genito-Urinary Cancer Group Autumn Meeting 2026
4 November - 5 November
EORTC HQ, Brussels, Belgium
27th Annual World Congress International Psycho-Oncology Society
9 November - 12 November
Barcelona, Spain
EORTC Diagnostic and Therapeutic Imaging Group Autumn Meeting 2026
13 November
EORTC HQ, Brussels, Belgium
38th EORTC-NCI-AACR Symposium
18 November - 20 November
Barcelona, Spain
